Home Industries Services Case Studies Blogs Custom Research Syndicate Services About Us Contact us
Home Industries Services Case Studies Blogs Custom Research Syndicate Services About Us Contact us

Pharmaceutical Filtration Market Size By Product Type (Membrane Filters, Filter Holders, Cartridges & Capsules, Prefilter & Depth Filter Media, Filtration Accessories, Single-Use Systems, and Others), By Application (Final Product Processing, Cell Separation, Raw Material Filtration, Water Purification, and Air Purification), By Technique (Nanofiltration, Microfiltration, Crossflow Filtration, Ultrafiltration, and Others), Regions, Segmentation, and Projection till 2030

CAGR: 11.9%Current Market Size: USD 20.1 BillionFastest Growing Region: APAC

Largest Market: North AmericaProjection Time: 2023-2030Base Year: 2022

Global Pharmaceutical Filtration Market- Market Overview:

The global pharmaceutical filtration market is expected to grow from USD 20.1 billion in 2022 to USD 49.4 billion by 2030, at a CAGR of 11.9% during the Projection period 2023-2030. The growth of the pharmaceutical filtration market is mainly driven by the rise in research and development activities.

The technique of separating solid particulate matter from fluids and gases using a porous medium is referred to as pharmaceutical filtration. Depending on the application and chemical solution, it can be done in a variety of ways. For example, ultrafiltration (UF) is a pressure-driven barrier that suspends microorganisms and produces products with high purity levels. It is frequently used in the separation, concentration, and purification of specific macromolecules as well as the production of vaccines, plasma, and serums. Furthermore, cross-flow filtration has recently been developed for the removal of total dissolved solids (TDS) in water. The global demand for generic pharmaceuticals has increased due to an increase in the prevalence of chronic diseases. This, along with tight rules for drug quality management, is one of the primary drivers driving market expansion. Furthermore, the increasing number of drug releases is encouraging the use of pharmaceutical filtering technologies to remove potential microorganisms during production procedures. Technological advances in the synthesis of big molecules and biologics are also supporting market expansion. Other factors contributing to market expansion include rising demand for sophisticated therapeutic pharmaceuticals and increased expenditure in research and development (R&D) projects. Furthermore, the leading corporations are concentrating their efforts on collaborations, partnerships, and mergers and acquisitions (M&A) activities. This will help these companies develop unique solutions for a variety of applications, such as bioburden testing, viral inactivation, and buffer preparation.

Sample Request: - Global Pharmaceutical Filtration Market

Market Dynamics:

Drivers:                          

  • Rising Drug Launches

The increased prevalence of chronic diseases increases the demand for a variety of medications. Chronic diseases such as cancer, diabetes, asthma, COPD, and arthritis are being treated with new medications. In most circumstances, drugs are tailored to the patient's specific health needs. The increased need for drugs to treat chronic diseases, as well as a large increase in the number of generic drug launches, are propelling the pharmaceutical filtration industry forward.

Restraints:                                             

  • Limited Resources

The capital required for pharmaceutical filtration is considerable, which limits the market's expansion. Although several hospitals with large capital budgets may afford these systems, local hospitals and academic organisations with limited resources find it difficult to participate in the pharmaceutical filtration sector. Healthcare providers in nations like as India, Mexico, and Brazil lack the financial resources to invest in such pricey technologies, which is expected to impede the system's implementation.

Opportunities:

  • Rising R&D

The increased amount of R&D efforts for developing generic medications and researching various healthcare therapies such as monoclonal antibodies, therapeutic proteins, and vaccines represents a growth opportunity for the industry. The government's increased investment to support research & development activities is also likely to fuel the market growth during the Projection period.

Challenges:

  • Stringent Regulations

Biopharmaceutical and pharmaceutical manufacture is strictly regulated. Several countries have rigorous laws governing the hygienic and quality of medications at each stage of the manufacturing process. As a result, employing traditional equipment to manufacture medications and biopharmaceuticals becomes prohibitively expensive and difficult. The pharmaceutical industry's tight restrictions pose a hindrance to the pharmaceutical filtration market's expansion.

Segmentation Analysis:

The global pharmaceutical filtration market has been segmented based on product type, application, technique, and region.

By Product Type

The product type segment is membrane filters, filter holders, cartridges & capsules, prefilter & depth filter media, filtration accessories, single-use systems, and others. The membrane filters segment led the largest share of the pharmaceutical filtration market with a market share of around 29.76% in 2022. Because of the rapid development of pharmaceuticals and biologics firms. These businesses are forming alliances and collaborations in order to achieve a larger market share. For example, in June 2016, Novartis and Xencor Inc. announced a strategic collaboration in which Novartis gained rights to develop T-cell-engaging bispecific antibodies for the treatment of acute myeloid leukaemia and B-cell malignancies. Membrane filters are frequently employed in research and development and production operations such as sterile filtering and end-of-life processes. As the prevalence of viral and chronic diseases such as anthrax, measles, influenza, tuberculosis, and chickenpox rises, the demand for sophisticated medications and vaccinations is projected to skyrocket in the near future.

By Application

The application segment is final product processing, cell separation, raw material filtration, water purification, and air purification. The air purification segment led the largest share of the pharmaceutical filtration market with a market share of around 3.87% in 2022. It is an essential procedure in all pharmaceutical and biopharmaceutical firms. The FDA has established regulations and criteria for the manufacture of pharmaceuticals and biologics. Air filtering devices must be utilized in industrial areas to control the recirculation of dust from manufacturing, according to 21 CFR 211.46(c). Manufacturers employ modern goods such as cartridges and capsules for air filtration. The Steridyne PVDF Membrane filter, for example, has wide chemical compatibility, making it perfect for filtration of harsh process gases like fermentation air, sterile tank venting, and compressed air & gases.

By Technique

The technique segment is nanofiltration, microfiltration, crossflow filtration, ultrafiltration, and others. The microfiltration segment led the largest share of the pharmaceutical filtration market with a market share of around 39.56% in 2022. Product development is one of the segment's primary motivators. Merck KGaA, for example, released a unique Viresolve Pro Shield H in 2016 that is aimed specifically at the removal of parvoviruses from therapeutic protein feed streams. Manufacturers utilize this approach extensively to separate big particles such as proteins and yeast from a liquid feed stream.

Global Pharmaceutical Filtration Market - Sales Analysis.

The sale of the pharmaceutical filtration market expanded at a CAGR of 10.2% from 2016 to 2022.

Filtration is a process used in the pharmaceutical and biopharmaceutical industries to separate particles from fluids by interposing a medium through which only the fluid can flow. Filtration promotes the production of microscopic and big molecules by preventing cross-contamination. This treatment is frequently coupled with others. To separate the materials, a single perforated layer is used. This method is used in water filtration, bulk & solvent filtration, and air filtration. The three categories of operations in the market are manufacturing-scale operations, pilot-scale operations, and R&D-scale activities. By controlling contamination, the filters help to keep the treated fluid sterile. Prefilters and depth media filters, cartridge and capsule filters, membrane filters, filter holders, and filtration accessories are all critical components of the filtration process for infection prevention.

This filtering process assists in the separation of suspended particles from a solution or medium. The pharmaceutical sector filters both sterile and nonsterile products extensively. Filters are also used to remove contaminants such as particulate matter and bacteria from solids, air, liquids, and gases. Pharmaceutical filtration techniques are also widely used in a wide range of applications, such as finished product processing, water treatment, input materials filtering, cell separation, and air purification.

Thus, owing to the aforementioned factors, the global pharmaceutical filtration market is expected to grow at a CAGR of 11.9% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the pharmaceutical filtration market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America region dominated the pharmaceutical filtration market and held a 37.8% share of the market revenue in 2022.

  • The North America region witnessed a major share. Pfizer Inc., Hoffmann-La Roche Ltd, Amgen Inc., and Merck KGaA are among the leading pharmaceutical and biopharmaceutical companies in North America. North America also has a well-developed healthcare infrastructure, providing lucrative growth potential for the pharmaceutical filtration industry.
  • Asia-Pacific is anticipated to experience significant growth during the Projection period. This region's expansion of pharmaceutical and biopharmaceutical industries has resulted in tremendous growth. Heavy investments by CMOs (Contract Manufacturing Organizations) and CROs (Contract Research Organizations) in the production of medicines and biologics, as well as less severe government regulations, work in these companies' favor, propelling market expansion. The availability of huge genomic pools and the development of healthcare infrastructure are two important factors driving market expansion.

Global Pharmaceutical Filtration Market - Country Analysis:

  • Germany

Germany's pharmaceutical filtration market size was valued at USD 1.45 billion in 2022 and is expected to reach USD 3.5 billion by 2030, at a CAGR of 12% from 2023 to 2030. Rising demand for biopharmaceuticals is also projected to fuel growth in this sector. Leading German market companies such as Merck KGaA and Sartorius Stedim Biotech S.A. have a large distribution network in the region. Because of the development of new systems and gadgets, the German region is able to acquire a significant share.

  • China

China’s pharmaceutical filtration market size was valued at USD 1.5 billion in 2022 and is expected to reach USD 3.7 billion by 2030, at a CAGR of 12.2% from 2023 to 2030. For prominent participants in the Pharmaceutical Filtration Market, China offers significant opportunities. Furthermore, advancements in healthcare infrastructure, an increase in the prevalence of diseases such as malaria, polio, and rabies, a robust R&D sector, enhanced healthcare reforms, and technological advances in the field of healthcare all contribute to market growth.

  • India

India's pharmaceutical filtration market size was valued at USD 1.2 billion in 2022 and is expected to reach USD 2.9 billion by 2030, at a CAGR of 12.1% from 2023 to 2030. India will have the largest market share due to the demand to maintain a clean manufacturing environment, the increased frequency of airborne diseases, and the rapid expansion of generics production in this region.

Key Industry Players Analysis:

To increase their market position in the global pharmaceutical filtration market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.   

  • Eaton Corporation Plc
  • GE Healthcare
  • Amazon Filters Ltd.
  • Merck KGaA
  • Danaher Corporation, Inc.
  • Sartorius Stedim Biotech S.A.
  • Thermo Fisher Scientific Inc.
  • Graver Technologies, LLC
  • 3M

Latest Development:

  • In August 2021, GE Healthcare announced a cooperation with Amazon Web Services (AWS) to provide hospitals and healthcare providers with AI and cloud-based imaging solutions.
  • In October 2021, GE Healthcare Partners with Apprise Health Insights to Launch the Nation's First Automated Statewide Hospital Bed Management Solution in Oregon.

Report Metrics

Report Attribute 

Details

Study Period

2022-2030

Base year

2022

CAGR (%)

11.9%

Market Size

20.1 billion in 2022

Projection period

2023-2030

Projection unit

Value (USD)

Segments covered

By Product Type, By Application, By Technique, and By Region.

Report Scope

Revenue Projection, competitive landscape, company ranking, growth factors, and trends

Companies covered

Eaton Corporation Plc, GE Healthcare, Amazon Filters Ltd., Merck KGaA, Danaher Corporation, Inc., Sartorius Stedim Biotech S.A., Thermo Fisher Scientific Inc., Graver Technologies, LLC, and 3M.

By Product Type

  • Membrane Filters
  • Filter Holders
  • Cartridges & Capsules
  • Prefilter & Depth Filter Media
  • Filtration Accessories
  • Single-Use Systems
  • Others      

By Application

  • Final Product Processing
  • Cell Separation
  • Raw Material Filtration
  • Water Purification
  • Air Purification     

By Technique

  • Nanofiltration
  • Microfiltration
  • Crossflow Filtration
  • Ultrafiltration
  • Others     

Regional scope

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Scope of the Report

Global Pharmaceutical Filtration Market By Product Type:

  • Membrane Filters
  • Filter Holders
  • Cartridges & Capsules
  • Prefilter & Depth Filter Media
  • Filtration Accessories
  • Single-Use Systems
  • Others

Global Pharmaceutical Filtration Market By Application:

  • Final Product Processing
  • Cell Separation
  • Raw Material Filtration
  • Water Purification
  • Air Purification

Global Pharmaceutical Filtration Market By Technique:

  • Nanofiltration
  • Microfiltration
  • Crossflow Filtration
  • Ultrafiltration
  • Others

Global Pharmaceutical Filtration Market By Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
  • Asia-Pacific
    • Japan
    • China
    • India
    • Korea
    • Southeast Asia
  • South America
    • Brazil
    • Peru
  • Middle East and Africa
    • UAE
    • South Africa
    • Saudi Arabia

Frequently Asked Questions

What will be the expected market size of the pharmaceutical filtration market in 2030?

Global pharmaceutical filtration market is expected to reach USD 49.4 billion by 2030.

What is the CAGR of the pharmaceutical filtration market?

The pharmaceutical filtration market is projected to have a CAGR of 11.9%.

What are the key factors for the growth of the pharmaceutical filtration market?

The increased prevalence of chronic diseases increases the demand for a variety of medications. Chronic diseases such as cancer, diabetes, asthma, COPD, and arthritis are being treated with new medications. In most circumstances, drugs are tailored to the patient's specific health needs.

Which are the leading market players active in the pharmaceutical filtration market?

Leading market players active in the global pharmaceutical filtration market are Merck KGaA, Meissner Filtration Products, Inc., GE Healthcare, Amazon Filters Ltd., Parker Hannifin Corporation, Pall Corporation, Eaton Corporation PLC, Sartorius Stedim Biotech S.A.,3M Company, Graver Technologies, LLC, among other